5/14
04:13 pm
antx
Form 10-Q AN2 Therapeutics, Inc. For: Mar 31
Low
Report
Form 10-Q AN2 Therapeutics, Inc. For: Mar 31
5/14
04:07 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: May 14
Low
Report
Form 8-K AN2 Therapeutics, Inc. For: May 14
5/14
04:02 pm
antx
Form 10-K/A AN2 Therapeutics, Inc. For: Dec 31
Low
Report
Form 10-K/A AN2 Therapeutics, Inc. For: Dec 31
4/26
04:25 pm
antx
Form ARS AN2 Therapeutics, Inc. For: Dec 31
Low
Report
Form ARS AN2 Therapeutics, Inc. For: Dec 31
4/26
04:21 pm
antx
Form DEFA14A AN2 Therapeutics, Inc.
Low
Report
Form DEFA14A AN2 Therapeutics, Inc.
4/26
04:16 pm
antx
Form DEF 14A AN2 Therapeutics, Inc. For: Jun 19
Low
Report
Form DEF 14A AN2 Therapeutics, Inc. For: Jun 19
4/10
04:45 pm
antx
Form SC 13G AN2 Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Low
Report
Form SC 13G AN2 Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
4/5
04:14 pm
antx
Form PRE 14A AN2 Therapeutics, Inc. For: Jun 19
Low
Report
Form PRE 14A AN2 Therapeutics, Inc. For: Jun 19
3/29
05:11 pm
antx
Form S-8 AN2 Therapeutics, Inc.
High
Report
Form S-8 AN2 Therapeutics, Inc.
3/29
04:25 pm
antx
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
High
Report
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
3/29
04:19 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Day Lucy
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Day Lucy
3/29
04:19 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eckburg Paul
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eckburg Paul
3/29
04:18 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eizen Joshua M
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eizen Joshua M
3/29
04:17 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Krause Kevin Michael
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Krause Kevin Michael
3/29
04:17 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Chanda Sanjay
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Chanda Sanjay
3/29
04:16 pm
antx
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Easom Eric
High
Report
Form 4/A AN2 Therapeutics, Inc. For: Mar 15 Filed by: Easom Eric
3/28
04:25 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 28
High
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 28
3/18
07:29 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Krause Kevin Michael
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Krause Kevin Michael
3/18
07:29 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eizen Joshua M
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eizen Joshua M
3/18
07:29 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Day Lucy
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Day Lucy
3/18
07:28 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Chanda Sanjay
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Chanda Sanjay
3/18
07:27 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eckburg Paul
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Eckburg Paul
3/18
07:26 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Easom Eric
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 15 Filed by: Easom Eric